- Home
- Publications
- Publication Search
- Publication Details
Title
Delivery strategies of RNA therapeutics to leukocytes
Authors
Keywords
RNA, Drug delivery, Leukocytes, Nanocarriers, mRNA
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 342, Issue -, Pages 362-371
Publisher
Elsevier BV
Online
2022-01-15
DOI
10.1016/j.jconrel.2022.01.016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation
- (2021) Christopher M. Bobba et al. Nature Communications
- Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics
- (2021) Niels Dammes et al. Nature Nanotechnology
- Exosome membrane-modified M2 macrophages targeted nanomedicine: Treatment for allergic asthma
- (2021) Weiya Pei et al. JOURNAL OF CONTROLLED RELEASE
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells
- (2020) Jing Chen et al. Nanomedicine-Nanotechnology Biology and Medicine
- RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
- (2020) Sarah Bajan et al. Cells
- Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
- (2020) Nuphar Veiga et al. ADVANCED DRUG DELIVERY REVIEWS
- Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosome‐based targeted RNA delivery for immune tolerance induction in skin transplantation
- (2020) Chunmin Li et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- The powerful world of antisense oligonucleotides: From bench to bedside
- (2020) Anaïs M. Quemener et al. Wiley Interdisciplinary Reviews-RNA
- siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
- (2020) Wei Tao et al. Science Translational Medicine
- Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
- (2020) Lei Hou et al. Frontiers in Immunology
- M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ siRNA Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects
- (2020) Hong Xiao et al. ACS Central Science
- Paving the Road for RNA Therapeutics
- (2020) Niels Dammes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
- (2020) Eleni Anastasiadou et al. CLINICAL CANCER RESEARCH
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
- (2020) N. N. Parayath et al. Nature Communications
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
- (2020) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy
- (2019) Xinlong Zang et al. MOLECULAR PHARMACEUTICS
- Messenger RNA therapy for rare genetic metabolic diseases
- (2019) Pedro Berraondo et al. GUT
- Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
- (2019) Nidhi Jyotsana et al. ANNALS OF HEMATOLOGY
- ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
- (2019) Chi-Ling Chiang et al. BLOOD
- Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands
- (2019) Melissa P. Lokugamage et al. ADVANCED MATERIALS
- Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency
- (2019) Brian Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
- (2019) Leroy Versteeg et al. Vaccines
- In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance
- (2019) Yue Zhang et al. BIOMATERIALS
- Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target
- (2019) Nuphar Veiga et al. JOURNAL OF CONTROLLED RELEASE
- siRNA/lipopolymer nanoparticles to arrest growth of chronic myeloid leukemia cells in vitro and in vivo
- (2018) Juliana Valencia-Serna et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A modular platform for targeted RNAi therapeutics
- (2018) Ranit Kedmi et al. Nature Nanotechnology
- Glimmers in illuminating the druggable genome
- (2018) Griffin Rodgers et al. NATURE REVIEWS DRUG DISCOVERY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficiency of lipid nanoparticles with an original cationic lipid as a siRNA delivery system for macrophages and dendritic cells
- (2018) Yasunori Uemura et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Engineering the Delivery System for CRISPR-Based Genome Editing
- (2018) Zachary Glass et al. TRENDS IN BIOTECHNOLOGY
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
- (2018) Jiehua Zhou et al. Theranostics
- The great escape: how cationic polyplexes overcome the endosomal barrier
- (2018) Tanja Bus et al. Journal of Materials Chemistry B
- mRNA-Based Protein Replacement Therapy for the Heart
- (2018) Ajit Magadum et al. MOLECULAR THERAPY
- Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
- (2018) Tyler E. Wagner et al. Nature Chemical Biology
- Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
- (2018) Nuphar Veiga et al. Nature Communications
- Aptamer-Targeted Attenuation of IL-2 Signaling in CD8 + T Cells Enhances Antitumor Immunity
- (2017) Anugraha Rajagopalan et al. MOLECULAR THERAPY
- Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
- (2017) Shoshy Mizrahy et al. MOLECULAR THERAPY
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model
- (2017) L D’Abundo et al. ONCOGENE
- Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint
- (2017) Yasmin Granot et al. SEMINARS IN IMMUNOLOGY
- Role of TLR9 in Oncogenic Virus-Produced Cancer
- (2017) Cecilia Martínez-Campos et al. VIRAL IMMUNOLOGY
- Advances in the delivery of RNA therapeutics: from concept to clinical reality
- (2017) James C. Kaczmarek et al. Genome Medicine
- Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma
- (2016) Yuran Xie et al. JOURNAL OF CONTROLLED RELEASE
- Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicines
- (2016) Inbal Hazan-Halevy et al. JOURNAL OF CONTROLLED RELEASE
- Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles
- (2016) Srinivas Ramishetti et al. JOURNAL OF DRUG TARGETING
- Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA
- (2016) Jessica L. Cohen et al. MOLECULAR PHARMACEUTICS
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Exosome-mediated small RNA delivery for gene therapy
- (2016) Yu Zhou et al. Wiley Interdisciplinary Reviews-RNA
- Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles
- (2015) Srinivas Ramishetti et al. ACS Nano
- Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
- (2015) Hyewon Youn et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Knocking down disease: a progress report on siRNA therapeutics
- (2015) Anders Wittrup et al. NATURE REVIEWS GENETICS
- Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
- (2015) Shiri Weinstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
- (2015) Donato Cosco et al. Scientific Reports
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
- (2014) Andreas Herrmann et al. JOURNAL OF CLINICAL INVESTIGATION
- SNS01-T Modulation of eIF5A Inhibits B-cell Cancer Progression and Synergizes With Bortezomib and Lenalidomide
- (2014) Sarah M Francis et al. MOLECULAR THERAPY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
- (2014) Maria Teresa Di Martino et al. PLoS One
- TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo
- (2013) Q. Zhang et al. BLOOD
- A daunting task: manipulating leukocyte function with RNAi
- (2013) Dan Peer IMMUNOLOGICAL REVIEWS
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
- (2012) V J Craig et al. LEUKEMIA
- Modulation of eIF5A Expression Using SNS01 Nanoparticles Inhibits NF-κB Activity and Tumor Growth in Murine Models of Multiple Myeloma
- (2012) Catherine A Taylor et al. MOLECULAR THERAPY
- Functional In Vivo Delivery of Multiplexed Anti-HIV-1 siRNAs via a Chemically Synthesized Aptamer With a Sticky Bridge
- (2012) Jiehua Zhou et al. MOLECULAR THERAPY
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
- (2012) I. A. Babar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
- (2012) Tatiana I Novobrantseva et al. Molecular Therapy-Nucleic Acids
- Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
- (2011) Lee Adam Wheeler et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic Administration of Combinatorial dsiRNAs via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice
- (2011) Jiehua Zhou et al. MOLECULAR THERAPY
- Therapeutic siRNA silencing in inflammatory monocytes in mice
- (2011) Florian Leuschner et al. NATURE BIOTECHNOLOGY
- An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice
- (2011) C. P. Neff et al. Science Translational Medicine
- Discovery and Development of Therapeutic Aptamers
- (2010) P.R. Bouchard et al. Annual Review of Pharmacology and Toxicology
- Targeting Stat3 in the Myeloid Compartment Drastically Improves the In vivo Antitumor Functions of Adoptively Transferred T Cells
- (2010) A. Herrmann et al. CANCER RESEARCH
- Endosomal escape pathways for delivery of biologicals
- (2010) Amir K. Varkouhi et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Delivery of siRNA to Macrophages for Anti-inflammatory Treatment
- (2010) Sang-Soo Kim et al. MOLECULAR THERAPY
- RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice
- (2009) Sang-Soo Kim et al. MOLECULAR THERAPY
- Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
- (2009) Myriam Aouadi et al. NATURE
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
- (2009) Marcin Kortylewski et al. NATURE BIOTECHNOLOGY
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS
- (2009) Pavan Brahmamdam et al. SHOCK
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
- (2008) Priti Kumar et al. CELL
- Chemical Modification of siRNAs for In Vivo Use
- (2008) Mark A. Behlke OLIGONUCLEOTIDES
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
- (2008) D. Peer et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started